ResearcherNational Institutes of HealthActive in the last 2 years

Craig J. Thomas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9386-9001; OpenAlex author ID A5014278257; NIH RePORTER profile ID 14380133. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 grant

Papers 2

Grants 1

HTS enabled examination of drug combinations ZIATR000047 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Iok In Christine Chio · 2 shared papers, 2019–2022 · strength 0.19
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
- Paper eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. DOI 10.1038/s41467-019-13086-5 ↗
Dan He · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Michael D. Kluger · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Michael Anthony Hollingsworth · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Paul M. Grandgenett · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Karina M. Chan · 1 shared paper, 2019 · strength 0.07
- Paper eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. DOI 10.1038/s41467-019-13086-5 ↗
Michaël Pollak · 1 shared paper, 2019 · strength 0.07
- Paper eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. DOI 10.1038/s41467-019-13086-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.